SWITCH PHARMACEUTICALS OÜ
Date of report 20.12.2024
Open the reports you want to print
Employees and salaries
SWITCH PHARMACEUTICALS OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
SWITCH PHARMACEUTICALS OÜ
Decision-makers?
Former decision-makers
Relations: 2
Turnover 2024: 7 008 637 €
Employees: 8
Irina Nikitina
★★★★
......
Credit Score: Trustworthy
Reputation score: 2440
Date of birth: ......
Active relations 2
*Every member of the management board may represent the private limited company in concluding all transactions.
SWITCH PHARMACEUTICALS OÜ
Former decision-makers?
Relations:
Turnover:
Employees:
Veronika Savina
★★★☆
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
Relations:
Turnover:
Employees:
Daria Abramova
★★★☆
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
SWITCH PHARMACEUTICALS OÜ
History of right of representation?
Field
Trading
Business age
3y
Beneficial country:
Germany
2021
2022
2023
2024
2021
2022
2023
2024
SWITCH PHARMACEUTICALS OÜ
Owners?
Former owners
SWITCH PHARMACEUTICALS OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
SWITCH PHARMACEUTICALS OÜ
GoodwillSWITCH PHARMACEUTICALS OÜ
Taxes paid and estimated average salariesSWITCH PHARMACEUTICALS OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
SWITCH PHARMACEUTICALS OÜ
Sales revenue by business areaSWITCH PHARMACEUTICALS OÜ
Sales revenue by countrySWITCH PHARMACEUTICALS OÜ
Financial indicators and prognosisSWITCH PHARMACEUTICALS OÜ
Financial raiting: "SATISFACTORY" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
SWITCH PHARMACEUTICALS OÜ
Annual reportsLiabilities and debts
SWITCH PHARMACEUTICALS OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
SWITCH PHARMACEUTICALS OÜ
Reports and assets-liabilities overview 20.12.2024?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
SWITCH PHARMACEUTICALS OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
SWITCH PHARMACEUTICALS OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | ...... € | ...... € | ...... € | ...... € | ...... |
SWITCH PHARMACEUTICALS OÜ
Bailiff's enforcement proceedings as of 20.12.2024?
Bailiff's enforcement proceedings MISSING
SWITCH PHARMACEUTICALS OÜ
Regulations of the Payment Order Department as of 20.12.2024?
Regulations of the Payment Order Department MISSING
SWITCH PHARMACEUTICALS OÜ
Court orders in the register as of 20.12.2024?
Hoiatusmäärus sundlõpetamiseks: ebapiisav netovara
25.06.2024
Regulation number: Ä 50183443 / M3
Regulation status has entered into force: 25.06.2024
Date of enforcement of order or additional period: 25.06.2024
Regulation status: Jõustunud
Puuduste kõrvaldamise määrus
30.01.2024
Regulation number: Ä 50183443 / M2
Regulation status has entered into force: 29.01.2024
Date of enforcement of order or additional period: 30.01.2024
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
17.09.2021
Regulation number: Ä 50183443 / M1
Regulation status has entered into force: 30.09.2021
Date of enforcement of order or additional period: 17.09.2021
Regulation status: Puudused kõrvaldatud
SWITCH PHARMACEUTICALS OÜ
Decisions of the Consumer Disputes Committee as of 20.12.2024?
Consumer disputes MISSING
SWITCH PHARMACEUTICALS OÜ
Court hearings as of 20.12.2024?
Court hearings MISSING
SWITCH PHARMACEUTICALS OÜ
Rulings as of 20.12.2024?
Court settlemets MISSING
SWITCH PHARMACEUTICALS OÜ
Notices and announcements as of 20.12.2024?
Announcements MISSING
Marketing
Business network
SWITCH PHARMACEUTICALS OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
SWITCH PHARMACEUTICALS OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.